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Introduction
•

•

•

•

•

•

•

Pulmonary arterial hypertension
(PAH) is a medical condition resulting
in alterations in the small arteries of
the lung.
There are many causes of PAH
including developmental
abnormalities of the heart leading to
increased pulmonary blood flow.
After birth, in the normal heart, the
blood flow is in series and does not
“mix”.
Specific cardiac defects involve
connections between the pulmonary
and systemic circulation allowing
blood to flow into the lower
resistance system.
As the resistance in the pulmonary
circulation falls following birth and
clamping of the umbilical cord,
connections between the two
systems allow oxygenated blood
returning from the lungs to recirculate
back to the lungs rather than being
delivered to the body.
Over time, pulmonary vasculature
with high blood flow contributes to
muscularization of the normally thin
walled pulmonary arteries resulting in
elevated pressure and increased
vascular resistance – the hallmarks
of PAH.
Depending upon the cardiac lesion
and the timing of repair, surgical
closure of these connections may not
improve PAH that is long-standing.

Presentation of Case
•
•
•

•

•

•

•
•

Why Researched
•

•

•

•

This topic is extremely relevant to the
field in which I work, as well as my
future career as a cardiac nurse.
I work as a Registered Nurse (RN) in
the Heart Center Float Pool at
Nationwide Children’s Hospital.
Children with CHD can in a matter of
minutes have situations of life and
death when they have pulmonary
hypertension and develop a crisis.
It is very important to be up to date
on the education and information that
is available for pulmonary
hypertension in order to educate
families on the disease.

Most cardiac defect s can now be diagnosed during
fetal life.
After birth the defect is confirmed with an
echocardiogram (ECHO).
If the lesion is associated with the risk of increased
pulmonary blood flow, monitoring for pulmonary
hypertension begins.
Children are monitored for both an increase in baseline
pulmonary artery pressures as well as a propensity to
have a pulmonary vascular bed that is capable of
constricting suddenly and severely precipitating what is
commonly called a pulmonary hypertensive crisis.
During a crisis, the abrupt elevation in pulmonary artery
pressure stuns the right ventricle causing it to fail. The
failing RV cannot eject blood into the lungs to preload
the left ventricle and with decreased systemic cardiac
output, the child’s blood pressure plummets.

•

•
Normal lung tissue

•

Signs and Symptoms
•

•

•

History of heart defects, underlying lung disease,
syncopal episodes with activity or stress (Park, p. 491)
Physical assessment- increased right ventricular
impulse, loud second heart sound, cyanosis, s/s of
right sided heart failure such as edema or
hepatomegaly, murmur that is associated with
pulmonary regurgitation , differential clubbing (Park, p.
491)
Children with pulmonary hypertension may have
dyspnea , fatigue, syncopal episodes (Park, p. 491)
Radiology exams- x-ray studies show normal to slightly
enlarged heart and pulmonary artery. EKG
demonstrates right ventricular hypertrophy. ECHO may
show a large RV and RA, thickened RV, pulmonary
regurgitation, and dilated proximal pulmonary arteries
(Park, p. 491)
Cardiac Catheterization- directly measures the pressure
within the RA and RV as well as the pulmonary bed.
“Right heart catheterization is still the gold standard for
the diagnosis of PAH and hemodynamic evaluation for
surgical correction and medical treatment of CHD
patients” (Fang et. El, p. 1066)
Clinical signs of a child experiencing a pulmonary
hypertensive crisis include abrupt rise in RA and
pulmonary artery pressures, decreased systemic blood
pressures, decreased heart rate, ST segment changes,
decreased cerebral saturations, and decreased pulse
oximetry.

Implications for
Nursing

Significance of
Pathophysiology

•

lung tissue with pulmonary hypertension

Underlying Pathophysiology
•
•

•

•

Prolonged exposure to high volume shunts prevents the normal
remodeling of the pulmonary arteries that occurs after birth.
Rather than thin walled vessels in the normal lung, arteries in PAH
become progressively thicker making the lumen of the vessel
progressively smaller.
“Progressive endothelial dysfunction, medial hypertrophy with
hyperplasia of smooth muscle cells, increased connective tissue and
elastic fibers, intimal and adventitial thickening and rarefication of the
pulmonary arterial tree” (D’Alto et. El p. 3).
When looking at any disease process, depending on when the
disease is found and how quickly the process is evolving, determines
the possibility of reversibility. At the end stage of the disease process
following long-term exposure to high volume shunts, the PAH may be
irreversible.

•

•

Diagnosis of the disease is
extremely important since
changes in pathophysiology
occur frequently and
abruptly.
Changes to the pulmonary
bed and the regurgitation of
the pulmonary valve cause
right ventricular stress and
ultimately failure.
The RV adapts to the stress
of PAH with hypertrophy or
thickening of the ventricular
wall leading to decreased
compliance with each
contraction and inadequate
pumping.
“Right ventricular contraction
occurs in a peristalsis-like
manner, beginning with
contraction of the inlet
portion and ending with
contraction of the
infundibulum” (Bronicki et. El,
p s15)
RV hypertrophy and pressure
affect the left ventricle's
ability to fill and eject
normally.
Over time, the RV severely
compresses the LV leading
to progressive decline and
death.

•

•
•

•

•

Avoid and limit strenuous
exercise. When looking at
this aspect for children it can
be complicated since eating
and playing are what they do.
(Park, p. 494)
Administer oxygen as needed
(Park, p. 494)
Administration of medications
as prescribed, avoidance of
abrupt discontinuation of
medications (Park, p. 496)
Ensure that when patient is
on inhaled Nitric Oxide (iNO)
that both the Respiratory
therapist (RRT) and nurse
collaborate for cares and
administration of iNO.
Sedation and analgesia for
painful or stimulating
procedures

Conclusion
•

•

•

Pulmonary hypertension is a
rare complication of
congenital heart disease in
children.
The clinical symptoms,
evaluation, and prognosis
varies greatly from adults.
Understanding the
pathophysiology and the
available medical therapies
and interventions allow us to
anticipate and prevent crisis
and stabilize or reverse the
early stages of PAH.
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